RespireRx Pharmaceuticals
Manufacturing · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
126 Valley Rd Ste C, Glen Rock, New Jers...Phone Number
(201) 444-4947Website
www.respirerx.comRevenue
<$5 MillionStock Symbol
RSPIIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About RespireRx Pharmaceuticals
RespireRX Pharmaceuticals Inc. is a biopharmaceutical company developing drug therapies for the treatment of sleep apnea, drug-induced respiratory depression, and other brain mediated breathing disorders. The company was founded in 1987 and is headquartered in Glen Rock, New Jersey.Explore more
RespireRx Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RespireRx Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
RespireRx Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on RespireRx Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at RespireRx Pharmaceuticals
Check out if RespireRx Pharmaceuticals is spiking on competitors!
Click to see if RespireRx Pharmaceuticals had a recent Job posting/layoffs
Check if RespireRx Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RespireRx Pharmaceuticals launches new products
Funding: Get notified immidiatlly once RespireRx Pharmaceuticals has new funding data
Recommended Actions
Find VP level buyers at RespireRx Pharmaceuticals
Find more new buyers
Compare Similar Companies to RespireRx Pharmaceuticals
Compare insights from companies similar to RespireRx Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
RespireRx Pharmaceuticals
<$5M
1-10
Public
-
1987
RW
Robert WeingartenMember of the Board of Directors, Chief Financial Officer and Vice President
Company Profile Activity
Activity Insights
RespireRx Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RespireRx Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RespireRx Pharmaceuticals.
RespireRx Pharmaceuticals Tech Stack
A closer look at the technologies used by RespireRx Pharmaceuticals
See more technologies
Most Recent Scoops
Project
Financial Planning
New Hire
Executive Move
New Hire
Funding
Executive Move
RespireRx Pharmaceuticals News & Media
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
Glen Rock, N.J., Nov. 20, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (RespireRx or the Company), and its subsidiaries, EndeavourRx LLC (EndeavourRx) and ResolutionRx Ltd (ResolutionRx), collectively, the RespireRx Group, leaders in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, today provides a progress and status report to its stockholders, stakeholders, strategic partners as well as other inteRespireRx Pharmaceuticals Inc. Announces NIH/NINDS Grant Award and Amended and Restated Patent License Agreement
Glen Rock, N.J., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the receipt of a Notice of Award of a grant from the NIH/NINDS and entry into an Amended and Restated Patent License Agreement with the University of Wisconsin Research Foundation.RespireRx Pharmaceuticals Inc. Announces SEC Order Making Findings and Revoking Registration of Securities and Future Plans with respect to its Common Stock
Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx”, “RSPI”, “Respondent” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, announces the receipt of an Order Making Findings and Revoking Registration of Securities Pursuant to Section 12(j) of the Securities Exchange Act of 1934.RespireRx Pharmaceuticals Inc. Announces Commencement of Rule 506(c) Private Placement
Glen Rock, N.J., Nov. 18, 2025 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the commencement of a Regulation D, Rule 506(c) exempt offering of securities, across the three entities of the RespireRx Group, RespireRx, EndeavourRx LLC and ResolutionRx Ltd (collectively, the RespireRx Group). T
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RespireRx Pharmaceuticals
Sign Up For FreeTo access detailed company insights
RespireRX Pharmaceuticals Inc. is a biopharmaceutical company developing drug therapies for the treatment of sleep apnea, drug-induced respiratory depression, and other brain mediated breathing disorders. The company was founded in 1987 and is headquartered in Glen Rock, New Jersey.... Read More
